TheraPsil

TheraPsil advances legal access to psychedelic-assisted therapy through world-class practitioner training, patient advocacy, clinical research, and policy reform. With over 1,000 trained therapists and healthcare providers across North America and beyond, TheraPsil brings rigorous, evidence-based training to practitioners ready to lead the next generation of psychedelic medicine — now including programs in the United States.